ACVA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at email@example.com.
Minutes of Proceedings
The witnesses made statements and answered questions.
Cathay Wagantall gave notice of the following motion:
That, pursuant to Standing Order 108(2), the committee undertake a study of no fewer than eight meetings regarding the anti-malaria drug commonly known as Mefloquine, Mefliam, Lariam, and other brand names; that the study encompass the complete history of the drug distributed to members of the Canadian Armed Forces (CAF), from its first distribution to the present day; that the study consider all aspects of the use of Mefloquine and other anti-malarial drugs by the CAF, including but not limited to its distribution, pricing, clinical testing, dosing, follow-up, side effects, a review of the latest research, a comparison with the experience of Canada’s allies, and other related topics; and that the committee report its findings to the House.
Questioning of the witnesses resumed.
At 6:12 p.m., the committee adjourned to the call of the Chair.